Pharmacy

Venture studio AION Labs' CEO Mati Gill says AION unites competing pharma companies in developing AI projects via a federated data platform, enabling pre-competitive collaboration while allowing each entity to isolate its own data.

The “Great Healthcare Plan” promotes a cost-sharing reduction program to cut premiums in the ACA.

Solicitor General D. John Sauer is urging the Supreme Court to deny AstraZeneca’s petition to hear the constitutionality of the case.

President Trump directed HHS and the CDC to evaluate the scientific evidence of childhood vaccinations in other peer, developed nations.

Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense.

Model enables state Medicaid agencies and Medicare Part D  to cover GLP-1 drugs.

HHS has appealed and has been joined by several pharmaceutical companies that want intervenor status.

Mail-order pharmacies run by UnitedHealth and Humana have the most cost overruns, says WSJ report.

Novo Nordisk has beaten Eli Lilly in releasing the first oral GLP-1 for weight loss in adults.

All community and independent pharmacies in the Optum Rx network are transitioning to cost-based contracts.